Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Auxiliary proteins are the predominant determinants of differential efficacy of clinical candidates acting as AMPA receptor positive allosteric modulators

Toshiyuki Ishii, Jacob R. Stolz and Geoffrey T Swanson
Molecular Pharmacology February 28, 2020, mol.119.118554; DOI: https://doi.org/10.1124/mol.119.118554
Toshiyuki Ishii
1 Nippon Medical School;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob R. Stolz
2 Northwestern University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey T Swanson
2 Northwestern University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

mol.119.118554
DOI 
https://doi.org/10.1124/mol.119.118554
PubMed 
32111699

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online February 28, 2020.

Article Versions

  • You are currently viewing an Earlier version of this article (February 28, 2020 - 04:51).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Toshiyuki Ishii1,
  2. Jacob R. Stolz2, and
  3. Geoffrey T Swanson2,*
  1. 1 Nippon Medical School;
  2. 2 Northwestern University
  1. ↵*Address correspondence to: gtswanson{at}northwestern.edu

Statistics from Altmetric.com

Article usage

Article usage: February 2020 to May 2023

AbstractFullPdf
Feb 20206808
Mar 20202595115
Apr 20203102142
May 20201462127
Jun 202052127
Jul 202052817
Aug 20204157
Sep 20206788
Oct 2020541617
Nov 20203165
Dec 20204858
Jan 2021741612
Feb 20214697
Mar 2021991211
Apr 2021742219
May 2021324024
Jun 2021114016
Jul 2021141714
Aug 2021126224
Sep 2021213632
Oct 2021123030
Nov 2021103445
Dec 202142721
Jan 2022102619
Feb 2022122831
Mar 2022114724
Apr 202262717
May 202262828
Jun 2022122012
Jul 202281718
Aug 2022133725
Sep 202211119
Oct 202263112
Nov 2022111511
Dec 202275210
Jan 202393211
Feb 202363012
Mar 20236204
Apr 202391313
May 20238149

Next
Back to top

In this issue

Molecular Pharmacology: 103 (6)
Molecular Pharmacology
Vol. 103, Issue 6
1 Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Auxiliary proteins are the predominant determinants of differential efficacy of clinical candidates acting as AMPA receptor positive allosteric modulators
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Auxiliary proteins are the predominant determinants of differential efficacy of clinical candidates acting as AMPA receptor positive allosteric modulators

Toshiyuki Ishii, Jacob R. Stolz and Geoffrey T Swanson
Molecular Pharmacology February 28, 2020, mol.119.118554; DOI: https://doi.org/10.1124/mol.119.118554

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Auxiliary proteins are the predominant determinants of differential efficacy of clinical candidates acting as AMPA receptor positive allosteric modulators

Toshiyuki Ishii, Jacob R. Stolz and Geoffrey T Swanson
Molecular Pharmacology February 28, 2020, mol.119.118554; DOI: https://doi.org/10.1124/mol.119.118554
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics